David A. Chorney

363 Sales As A Health Care M&A Tool, Part 2 – Pros And Cons For Buyers And Sellers

363 Sales As A Health Care M&A Tool, Part 1 – Overview

Massachusetts Considers Drug Pricing Transparency Laws

Three Things To Learn From Delaware Supreme Court's Opinion On Board Of Director Oversight Duties (Marchand v. Barnhill)

FDA And Outgoing Commissioner Scott Gottlieb Open Up About Cannabis And CBD Regulation

How To Safely And Productively Promote An FDA-Regulated Medical Product

Physician's Response To A Public Patient Complaint Leads To Penalty Under HIPAA

Six Things To Know About The New Section 1332 Waiver Guidance